Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 4176 - 4200 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Diacylglycerophosphoinositolglycans LMGP15010160
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:0/16:1(9Z))
126457528 1484.752783 C67H121O33P
Diacylglycerophosphoinositolglycans LMGP15010165
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:1(9Z)/16:0)
126457533 1484.752783 C67H121O33P
Gangliosides LMSP0601CI05
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
52931293 1483.912652 C73H133N3O27
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI07
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260554 1482.917403 C74H134N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC07
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Lewis a(d18:1/24:1(15Z))
44260634 1482.917403 C74H134N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AD07
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • type I H antigen(d18:1/24:1(15Z))
44260642 1482.917403 C74H134N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB07
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Lex-5(d18:1/24:1(15Z))
44260986 1482.917403 C74H134N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD07
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • type II antigen(d18:1/24:1(15Z))
44261002 1482.917403 C74H134N2O27
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AV07
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261610 1482.917403 C74H134N2O27
Diacylglycerophosphoinositolglycans LMGP15010161
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:0/16:2(9Z,12Z))
126457529 1482.737133 C67H119O33P
Diacylglycerophosphoinositolglycans LMGP15010166
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:1(9Z)/16:1(9Z))
126457534 1482.737133 C67H119O33P
Diacylglycerophosphoinositolglycans LMGP15010171
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:2(9Z,12Z)/16:0)
126457539 1482.737133 C67H119O33P
Diacylglycerophosphoinositolglycans LMGP15010167
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:1(9Z)/16:2(9Z,12Z))
126457535 1480.721483 C67H117O33P
Diacylglycerophosphoinositolglycans LMGP15010172
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:2(9Z,12Z)/16:1(9Z))
126457540 1480.721483 C67H117O33P
Diacylglycerophosphoinositolglycans LMGP15010173
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:2(9Z,12Z)/16:2(9Z,12Z))
126457541 1478.705833 C67H115O33P
Gangliosides LMSP0601DD01
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262580 1476.818813 C69H124N2O31
Gangliosides LMSP0601DF01
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • KDN-GM1(d18:1/16:0)
44262596 1476.818813 C69H124N2O31
Gangliosides LMSP0601EB01
  • KDN-lactotetraosylceramide(d18:1/16:0)
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262756 1476.818813 C69H124N2O31
Gangliosides LMSP0601EC01
  • KDN(2-6)lactotetraosylceramide(d18:1/16:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262764 1476.818813 C69H124N2O31
Gangliosides LMSP0601GE01
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44263164 1476.818813 C69H124N2O31
Gangliosides LMSP0601GG01
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/16:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44263180 1476.818813 C69H124N2O31
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE04
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • SSEA-3 antigen(d18:1/22:0)
44260199 1472.896668 C72H132N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AP04
  • GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260287 1472.896668 C72H132N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BA04
  • Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260375 1472.896668 C72H132N2O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BK04
  • Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260455 1472.896668 C72H132N2O28

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024